日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Safety and Immunogenicity of Monovalent Omicron KP.2-Adapted BNT162b2 COVID-19 Vaccine in Adults: Single-Arm Substudy from a Phase 2/3 Trial

单价 Omicron KP.2 适应性 BNT162b2 COVID-19 疫苗在成人中的安全性和免疫原性：一项 2/3 期试验的单臂子研究

期刊:Infectious Diseases and Therapy
影响因子:5.3
doi:10.1007/s40121-025-01185-4
Diya, Oyeniyi; Gayed, Juleen; Lowry, Francine S; Ma, Hua; Bangad, Vishva; Mensa, Federico; Zou, Jing; Xie, Xuping; Hu, Yanping; Cutler, Mark; Belanger, Todd; Cooper, David; Xu, Xia; Mogg, Robin; Türeci, Özlem; Şahin, Uǧur; Swanson, Kena A; Modjarrad, Kayvon; Anderson, Annaliesa S; Gurtman, Alejandra; Kitchin, Nicholas
免疫/内分泌
发表日期：2025
文献求助 收藏

National- and State-Level Trends in Medicare Hospice Beneficiaries for Stroke During 2013 to 2019 in the United States

2013年至2019年美国医疗保险临终关怀受益人中风病例的国家和州级趋势

期刊:Stroke
影响因子:8.9
doi:10.1161/STROKEAHA.123.045021
de Havenon, Adam; Skolarus, Lesli E; Mac Grory, Brian; Bangad, Aaron; Sheth, Kevin N; Burke, James F; Creutzfeldt, Claire J
中风
心血管
发表日期：2024
文献求助 收藏

Safety and Immunogenicity of the Monovalent Omicron XBB.1.5-Adapted BNT162b2 COVID-19 Vaccine in Individuals ≥12 Years Old: A Phase 2/3 Trial

单价 Omicron XBB.1.5 改良型 BNT162b2 COVID-19 疫苗在 12 岁及以上人群中的安全性和免疫原性：一项 2/3 期试验

期刊:Vaccines
影响因子:3.4
doi:10.3390/vaccines12020118
Gayed, Juleen; Diya, Oyeniyi; Lowry, Francine S; Xu, Xia; Bangad, Vishva; Mensa, Federico; Zou, Jing; Xie, Xuping; Hu, Yanping; Lu, Claire; Cutler, Mark; Belanger, Todd; Cooper, David; Koury, Kenneth; Anderson, Annaliesa S; Türeci, Özlem; Şahin, Uǧur; Swanson, Kena A; Modjarrad, Kayvon; Gurtman, Alejandra; Kitchin, Nicholas
免疫/内分泌
发表日期：2024
文献求助 收藏

Immunogenicity of the Monovalent Omicron XBB.1.5-Adapted BNT162b2 COVID-19 Vaccine against XBB.1.5, BA.2.86, and JN.1 Sublineages: A Phase 2/3 Trial

单价 Omicron XBB.1.5 适应性 BNT162b2 COVID-19 疫苗对 XBB.1.5、BA.2.86 和 JN.1 亚系的免疫原性：一项 2/3 期试验

期刊:Vaccines
影响因子:3.4
doi:10.3390/vaccines12070734
Gayed, Juleen; Bangad, Vishva; Xu, Xia; Mensa, Federico; Cutler, Mark; Türeci, Özlem; Şahin, Uǧur; Modjarrad, Kayvon; Swanson, Kena A; Anderson, Annaliesa S; Gurtman, Alejandra; Kitchin, Nicholas
免疫/内分泌
发表日期：2024
文献求助 收藏

Bivalent Omicron BA.1-Adapted BNT162b2 Booster in Adults Older than 55 Years

55岁以上成人使用二价奥密克戎BA.1适应性BNT162b2加强针

期刊:New England Journal of Medicine
影响因子:78.5
doi:10.1056/NEJMoa2213082
Winokur, Patricia; Gayed, Juleen; Fitz-Patrick, David; Thomas, Stephen J; Diya, Oyeniyi; Lockhart, Stephen; Xu, Xia; Zhang, Ying; Bangad, Vishva; Schwartz, Howard I; Denham, Douglas; Cardona, Jose F; Usdan, Lisa; Ginis, John; Mensa, Federico J; Zou, Jing; Xie, Xuping; Shi, Pei-Yong; Lu, Claire; Buitrago, Sandra; Scully, Ingrid L; Cooper, David; Koury, Kenneth; Jansen, Kathrin U; Türeci, Özlem; Şahin, Uğur; Swanson, Kena A; Gruber, William C; Kitchin, Nicholas
发表日期：2023
文献求助 收藏

Understanding Patterns of Missingness in Acute Ischemic Stroke Trials: A Secondary Analysis of Pooled Participant-Level Follow-Up Data

了解急性缺血性卒中试验中缺失数据的模式：对汇总的参与者水平随访数据的二次分析

期刊:Stroke
影响因子:8.9
doi:10.1161/STROKEAHA.122.042168
de Havenon, Adam; Bangad, Aaron; Skolarus, Lesli E; Aldridge, Chad M; Braun, Robynne G; Cole, John W; Cramer, Steven C; Lindgren, Arne G; Sunmonu, N Abimbola; Worrall, Bradford B; Lohse, Keith R
发表日期：2023
文献求助 收藏

Secondary Ischemic Stroke Prevention

二级缺血性卒中预防

期刊:Neurotherapeutics
影响因子:6.9
doi:10.1007/s13311-023-01352-w
Bangad, Aaron; Abbasi, Mehdi; de Havenon, Adam
发表日期：2023
文献求助 收藏

Improvement in the Prediction of Cerebrovascular Events With White Matter Hyperintensity

白质高信号对脑血管事件预测的改进

期刊:Journal of the American Heart Association
影响因子:5.3
doi:10.1161/JAHA.123.029374
de Havenon, Adam; Smith, Eric E; Sharma, Richa; Falcone, Guido J; Bangad, Aaron; Prabhakaran, Shyam; Sheth, Kevin N
信号转导
神经科学
发表日期：2023
文献求助 收藏